Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Greetings, and welcome to the Pelthos Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please ...
Ruvidar and Rutherrin show strong potential in treating bladder cancer, solid tumors, and HSV-1—including drug-resistant ...
Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil ...
She was shocked to see her hand become red and swollen: "A silly paper cut did all this!" It’s a reminder all cuts can become ...
Conference call scheduled for November 13, 2025 at 8:00am ET Commercial launch of ZELSUVMI, the first FDA-approved at-home ...
Clinicians must adapt to the new reality of HFMD, as emerging strains drive serious complications and challenge old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback